Recent Company News

• 08:23 AM ET Oct 13, 2025
  

  StreetAccount Themes Headlines (13-Oct)

• 04:11 AM ET Oct 13, 2025
  

  Aspen Pharmacare Holdings announce South African Health Products Regulatory Authority has approved new indication for Mounjaro as chronic weight management treatment (ZAR 98.53, -0.41)

• 01:44 AM ET Oct 01, 2025
  

  Aspen Pharmacare Holdings upgraded to equal weight from underweight at Absa Bank (ZAR 94.77, 0.00)

• 02:23 AM ET Sep 08, 2025
  

  Aspen Pharmacare Holdings upgraded to neutral from underweight at Nedbank Capital (ZAR 103.93, 0.00)

• 02:04 AM ET Sep 05, 2025
  

  Aspen Pharmacare Holdings upgraded to neutral from underweight at JPMorgan (ZAR 102.80, 0.00)

• 07:12 AM ET Sep 03, 2025
  

  Aspen Pharmacare Holdings reports FY normalised HEPS ZAR10.56, lowers dividend (41%) y/y, guides FY26 (ZAR 104.32, +1.22)

• 04:05 AM ET Aug 22, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 11:46 AM ET Aug 21, 2025
  

  Aspen Pharmacare Holdings FY Trading Update: Commercial Pharmaceuticals has delivered double digit revenue and normalised EBITDA growth in constant exchange rate (ZAR 111.92, 0.00)

• 07:45 PM ET May 07, 2025
  

  Aspen Pharmacare Holdings downgraded to equal-weight from overweight at Morgan Stanley (ZAR 118.92, 0.00)

• 02:14 AM ET May 06, 2025
  

  Aspen Pharmacare Holdings downgraded to underweight from equal weight at Absa Bank (ZAR 119.26, 0.00)